Arcturus Therapeutics (NASDAQ:ARCT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Arcturus Therapeutics beat estimated earnings by 63.91%, reporting an EPS of $-0.61 versus an estimate of $-1.69.
Revenue was up $31.77 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.77 which was followed by a 19.22% drop in the share price the next day.
Here’s a look at Arcturus Therapeutics’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | 0.06 | 0.98 | -1.81 |
| EPS Actual | -1.98 | 0.62 | 4.33 | -1.33 |
| Revenue Estimate | 48.50M | 37.94M | 72.68M | 3.42M |
| Revenue Actual | 10.52M | 80.28M | 160.29M | 13.37M |
To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
